Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-20-004352

Options or other derivatives

  • CFO & SVP Finance acquired 616,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Roberts Brandi CFO & SVP Finance 2020-03-17 Grant or award · Employee Stock Option (Right to Buy) +616,700 616,700 D
Loading xslF345X03/ownership.xml…